Ensuring Access to Essential Drugs Act
Official title: To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ensuring Access to Essential Drugs Act
This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.
Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1922: Ensuring Access to Essential Drugs Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1922/
"H.R. 1922: Ensuring Access to Essential Drugs Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1922/.
H.R. 1922, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1922/.
[H.R. 1922: Ensuring Access to Essential Drugs Act](https://openamerica.io/bill/119-HR-1922/)